These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34927367)

  • 1. Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin-deficient and mdx mice.
    White Z; Theret M; Milad N; Tung LW; Chen WW; Sirois MG; Rossi F; Bernatchez P
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):544-560. PubMed ID: 34927367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice.
    White Z; Sun Z; Sauge E; Cox D; Donen G; Pechkovsky D; Straub V; Francis GA; Bernatchez P
    Skelet Muscle; 2022 Nov; 12(1):25. PubMed ID: 36447272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermoneutral Housing and a Western Diet Combination Exacerbates Dysferlin-Deficient Muscular Dystrophy.
    Donen GS; White Z; Sauge E; Ritso M; Theret M; Boyd J; Devlin AM; Rossi FMV; Bernatchez P
    Muscle Nerve; 2022 Oct; 66(4):513-522. PubMed ID: 35859452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B.
    White Z; Milad N; Tehrani AY; Chen WW; Donen G; Sellers SL; Bernatchez P
    PLoS One; 2019; 14(8):e0220903. PubMed ID: 31404091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance quantification of skeletal muscle lipid infiltration in a humanized mouse model of Duchenne muscular dystrophy.
    Khattri RB; Batra A; Matheny M; Hart C; Henley-Beasley SC; Hammers D; Zeng H; White Z; Ryan TE; Barton E; Bernatchez P; Walter GA
    NMR Biomed; 2023 Mar; 36(3):e4869. PubMed ID: 36331178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.
    Sellers SL; Milad N; White Z; Pascoe C; Chan R; Payne GW; Seow C; Rossi F; Seidman MA; Bernatchez P
    J Lipid Res; 2018 Feb; 59(2):261-272. PubMed ID: 29175948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma.
    Hosur V; Kavirayani A; Riefler J; Carney LM; Lyons B; Gott B; Cox GA; Shultz LD
    Cancer Genet; 2012 May; 205(5):232-41. PubMed ID: 22682622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy.
    Vila MC; Rayavarapu S; Hogarth MW; Van der Meulen JH; Horn A; Defour A; Takeda S; Brown KJ; Hathout Y; Nagaraju K; Jaiswal JK
    Cell Death Differ; 2017 Feb; 24(2):330-342. PubMed ID: 27834955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.
    Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K
    J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit.
    Sreetama SC; Chandra G; Van der Meulen JH; Ahmad MM; Suzuki P; Bhuvanendran S; Nagaraju K; Hoffman EP; Jaiswal JK
    Mol Ther; 2018 Sep; 26(9):2231-2242. PubMed ID: 30166241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.
    Nagaraju K; Rawat R; Veszelovszky E; Thapliyal R; Kesari A; Sparks S; Raben N; Plotz P; Hoffman EP
    Am J Pathol; 2008 Mar; 172(3):774-85. PubMed ID: 18276788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
    Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
    Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy.
    Renzini A; Marroncelli N; Cavioli G; Di Francescantonio S; Forcina L; Lambridis A; Di Giorgio E; Valente S; Mai A; Brancolini C; Giampietri C; Magenta A; De Santa F; Adamo S; Coletti D; Moresi V
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1339-1359. PubMed ID: 35170869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.
    Wehling-Henricks M; Jordan MC; Gotoh T; Grody WW; Roos KP; Tidball JG
    PLoS One; 2010 May; 5(5):e10763. PubMed ID: 20505827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy.
    Amor F; Vu Hong A; Corre G; Sanson M; Suel L; Blaie S; Servais L; Voit T; Richard I; Israeli D
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):677-693. PubMed ID: 34037326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H
    Hughes MC; Ramos SV; Turnbull PC; Rebalka IA; Cao A; Monaco CMF; Varah NE; Edgett BA; Huber JS; Tadi P; Delfinis LJ; Schlattner U; Simpson JA; Hawke TJ; Perry CGR
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):643-661. PubMed ID: 30938481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.